Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid:29513961 | ||||
pmid:28627258 | ||||
pmid:28403501 | ||||
pmid:27997878 | ||||
pmid:27329304 | ||||
pmid:26454138 | ||||
pmid:26117531 | ||||
pmid:25951322 | ||||
pmid:25618017 | ||||
pmid:25452227 | ||||
pmid:24806456 | ||||
pmid:24463070 | ||||
pmid:24168329 | ||||
pmid:23962801 | ||||
pmid:23797329 | ||||
pmid:23771412 | ||||
Morad SA et al. | A novel semisynthetic inhibitor of the FRB domain of mammalian target of rapamycin blocks proliferation and triggers apoptosis in chemoresistant prostate cancer cells. | 2013 | Mol. Pharmacol. | pmid:23208958 |
pmid:23013292 | ||||
pmid:22167571 | ||||
Chashoo G et al. | Potentiation of the antitumor effect of 11-keto-β-boswellic acid by its 3-α-hexanoyloxy derivative. | 2011 | Eur. J. Pharmacol. | pmid:21821018 |